VYGR - Voyager Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - VYGR (1640266)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
41 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-02-21
VYGRSwartz RobinCOOS - Sale$7.45-3,966118,361-3%-$29,547
2024-02-21
VYGRSandrock AlfredPres, CEOS - Sale$7.46-13,033334,954-4%-$97,226
2024-02-21
VYGRPfreundschuh Peter P.CFOS - Sale$7.46-3,764175,669-2%-$28,079
M
2024-02-20
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$7.50-3,96787,627-4%-$29,760
2024-01-17
VYGRSwartz RobinCOOS - Sale$7.15-2,54372,327-3%-$18,182
2024-01-17
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$7.18-1,26653,094-2%-$9,090
2023-10-03
VYGRPfreundschuh Peter P.CFOS - Sale$6.99-13,567149,433-8%-$94,833
D
2023-09-15
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale+OE$8.16-10,50054,360-16%-$85,680
2023-07-06
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$10.80-5,50059,860-8%-$59,400
D
2023-06-30
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale+OE$11.41-5,00065,360-7%-$57,050
2023-04-03
VYGRSandrock AlfredPres, CEOS - Sale$7.83-7,437214,618-3%-$58,232
2023-04-03
VYGRSwartz RobinCOOS - Sale$7.83-1,25971,617-2%-$9,858
2023-03-20
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$7.76-2,19365,360-3%-$17,018
2023-03-20
VYGRSwartz RobinCOOS - Sale$7.76-3,65472,876-5%-$28,355
2023-03-20
VYGRHesslein Robert W.SVP, GCS - Sale$7.76-4,410102,200-4%-$34,222
2023-03-15
VYGRSwartz RobinCOOS - Sale$8.20-15,37376,530-17%-$126,059
2023-02-23
VYGRNeurocrine Biosciences Inc10%P - Purchase$8.88+4,395,5888,575,316+105%+$39,032,821
2023-02-17
VYGRHesslein Robert W.SVP, GCS - Sale$7.45-3,297106,610-3%-$24,563
D
2023-02-17
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale+OE$7.45-73867,553-1%-$5,498
2023-02-13
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$7.67-79734,291-2%-$6,113
2023-02-13
VYGRHesslein Robert W.SVP, GCS - Sale$7.67-2,868109,907-3%-$21,998
M
2023-01-30
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$9.23-388,6424,721,992-8%-$3,587,443
2023-01-27
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$9.02-50,0005,110,634-1%-$451,000
M
2023-01-24
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$9.25-150,0005,160,634-3%-$1,388,000
M
2023-01-20
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$9.12-155,0005,310,634-3%-$1,413,300
2023-01-17
VYGRHesslein Robert W.SVP, GCS - Sale$9.85-2,188112,775-2%-$21,549
2023-01-17
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$9.85-1,10635,088-3%-$10,892
2023-01-17
VYGRSwartz RobinCOOS - Sale$9.85-2,18851,903-4%-$21,549
M
2023-01-09
VYGREcor1 Capital, LLC10%S - Sale$7.91-902,4003,851,507-19%-$7,142,343
2023-01-06
VYGRCarter Todd AlfredChief Scientific OfficerS - Sale$6.41-38836,194-1%-$2,487
M
2022-08-24
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$6.16-349,9725,465,634-6%-$2,157,329
2022-08-16
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$6.04-128,4565,815,606-2%-$775,874
M
2022-08-12
VYGRThird Rock Ventures Iii, L.P.10%S - Sale$6.10-483,8155,944,062-8%-$2,950,083
2022-07-14
VYGRPierce GlennDirS - Sale$6.70-9,51221,788-30%-$63,730
2022-07-14
VYGRHiggins Michael JDirS - Sale$6.70-13,89131,314-31%-$93,070
M
2022-06-21
VYGREcor1 Capital, LLC10%P - Purchase$5.58+477,4004,753,907+11%+$2,662,047
2022-04-04
VYGRSwartz RobinCOOS - Sale$8.25-1,52752,060-3%-$12,598
2022-04-04
VYGRHesslein Robert W.SVP, GCS - Sale$8.25-2,786114,963-2%-$22,985
2022-03-21
VYGRSwartz RobinCOOS - Sale$8.29-4,41353,587-8%-$36,604
2022-03-21
VYGRHesslein Robert W.SVP, GCS - Sale$8.29-4,955117,749-4%-$41,100
2022-03-21
VYGRBurek JulieVP, FinanceS - Sale$8.29-2,64952,458-5%-$21,972

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top